University of California San Francisco
Give to UCSFA community-led project to provide comprehensive COVID-19 testing to residents, essential workers, and first responders in the town of Bolinas has determined that all of the 1,845 nasal and oral swab tests conducted in the community between April 20 and April 24 were negative for active infection with the novel coronavirus SARS-CoV-2, which causes COVID-19.
An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be cautious.
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
While the widely used coronavirus PCR tests take about four hours to produce a result from a respiratory sample, the new DETECTR test developed by UCSF scientists takes only 45 minutes, rapidly accelerating the pace of diagnosis.
Lung damage is the cause of most COVID-19 deaths, and lung damage also is a public health concern for smokers and anybody living under polluted skies.
To provide officials with a set of best practices for mask decontamination, a nationwide team has launched N95decon.org, a website that distills a broad range of relevant scientific literature.
UCSF was awarded nearly 1,300 NIH grants and contracts, amounting to more than $684.4 million in funding.
The online study would try to help researchers gain insight into how the virus is spreading and identify ways to predict and reduce the number of new infections.
Though many hopes are hanging on the development of a vaccine or drug that targets the novel coronavirus directly, a UCSF-led team is taking an unconventional approach: target the host – in other words, you.
Thousands of UCSF health care workers are mobilizing to prepare for the potential influx of patients sickened by COVID-19, even as hundreds of UCSF scientists race against time to defeat the deadly respiratory virus impacting communities around the world.